• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

8 drug delivery innovations you need to know

February 25, 2021 By Sean Whooley

Closed-loop insulin delivery

Image from Tandem Diabetes

Closed-loop insulin delivery isn’t a totally new innovation but it continues to penetrate the diabetes care market.

Tandem Diabetes Care (NSDQ:TNDM) is at the forefront of the space, with its t:slim X2 insulin pump and Control-IQ advanced hybrid closed-loop technology to control Type 1 diabetes. The system, which is compatible with Dexcom’s (NSDQ:DXCM) G6 continuous glucose monitor (CGM) and Abbott’s FreeStyle Libre CGM, was approved by the FDA in December 2019.

Medtronic (NYSE:MDT) also has a closed-loop insulin delivery system: the MiniMed, which was the first system of its kind to win clearance globally in 2016. Medtronic and Tandem last summer inked a non-exclusive patent cross-license agreement related to their diabetes treatment tech as they both develop competing products.

The closed-loop automated insulin delivery systems can track glucose levels, or in Tandem’s case, pair with CGMs that track the levels, and automatically administer or withhold insulin depending upon the readings. They’ve also been referred to as the artificial pancreas.

While the technology has been on the market for a few years, there remains room to grow in the automated insulin delivery space for closed-loop systems.

Honorable mention: Medtronic in November 2020 launched its InPen “smart” insulin pen integrated with real-time Guardian Connect continuous glucose monitor (CGM) data. It touts the device as the first and only FDA-cleared smart insulin pen on the market for people on multiple daily insulin injections.

Next>>

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9

Filed Under: Auto-injectors, Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Hydrogels, Otolaryngology Ear, Nose & Throat, Pharmaceuticals, Research & Development, Respiratory, Technology Tagged With: dyvebioscience, Enable Injections, evoxtherapeutics, Inovio Pharmaceuticals, Johns Hopkins, Lyra Therapeutics, Medtronic, Tandem Diabetes Care, Teva, Teva Pharmaceuticals, Teva Respiratory

IN CASE YOU MISSED IT

  • Another BD Alaris infusion pump recall is Class I
  • Amgen completes $1.9B acquisition of Five Prime Therapeutics
  • Oncopeptides seeks EU marketing authorization for multiple myeloma treatment
  • Horizon touts data from trials for thyroid eye disease infusion treatment
  • Genentech touts study results for spinal muscular atrophy drug in babies

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS